Your browser doesn't support javascript.
loading
Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
Yang, Xiaofei; Dai, Haiping; Kang, Liqing; Qu, Changju; Li, Zheng; Yin, Jia; Qiu, Huiying; Fu, Chengcheng; Han, Yue; Jin, Zhengming; Ma, Xiao; Zhu, Xiamin; Yu, Lei; Wu, Depei; Tang, Xiaowen.
Afiliação
  • Yang X; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
  • Dai H; Institute of Blood and Marrow Transplantation, Suzhou, China.
  • Kang L; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Qu C; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
  • Li Z; Institute of Blood and Marrow Transplantation, Suzhou, China.
  • Yin J; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Qiu H; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Fu C; Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China.
  • Han Y; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
  • Jin Z; Institute of Blood and Marrow Transplantation, Suzhou, China.
  • Ma X; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Zhu X; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
  • Yu L; Institute of Blood and Marrow Transplantation, Suzhou, China.
  • Wu D; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Tang X; National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
Hematol Oncol ; 37(5): 655-658, 2019 Dec.
Article em En | MEDLINE | ID: mdl-31656047
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Pós-Operatórios / Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Antígenos CD19 / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Pós-Operatórios / Receptores de Antígenos de Linfócitos T / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Imunoterapia Adotiva / Antígenos CD19 / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article